Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women

키워드

참고문헌 (72)

1. Kaeberlein M, "Healthy aging : the ultimate preventative medicine", Science, 350, pp.1191~1193 (2015)
2. Kontis V, "Future life expectancy in 35 industrialised countries : projections with a Bayesian model ensemble", Lancet, 389, pp.1323~1335 (2017)
3. Mokdad AH, "The continuing epidemics of obesity and diabetes in the United States", JAMA, 286, pp.1195~1200 (2001)
4. Sehl ME, "Kinetics of human aging : I. Rates of senescence between ages 30 and 70 years in healthy people", J Gerontol A Biol Sci Med Sci, 56, pp.B198~B208 (2001)
5. Grune T, "Age-related changes in protein oxidation and proteolysis in mammalian cells", J Gerontol A Biol Sci Med Sci, 56, pp.B459~B467 (2001)
6. Balagopal P, "Effects of aging on in vivo synthesis of skeletal muscle myosin heavychain and sarcoplasmic protein in humans", Am J Physiol, 273, pp.E790~E800 (1997)
7. Volpi E, "Basal muscle amino acid kinetics and protein synthesis in healthy young and older men", JAMA, 286, pp.1206~1212 (2001)
8. Young VR, "Amino acids and proteins in relation to the nutrition of elderly people", Age Ageing, 19, pp.S10~S24 (1990)
9. Baumgartner RN, "Cross-sectional age differences in body composition in persons 60+ years of age", J Gerontol A Biol Sci Med Sci, 50, pp.M307~M316 (1995)
10. Forbes GB, "Longitudinal changes in adult fat-free mass : influence of body weight", Am J Clin Nutr, 70, pp.1025~1031 (1999)
11. Lizcano F, "Estrogen deficiency and the origin of obesity during menopause", Biomed Res Int, 2014, pp.757461~ (2014)
12. Karvonen-Gutierrez C, "Association of mid-life changes in body size, body composition and obesity status with the menopausal transition", Healthcare (Basel), 4, pp.42~ (2016)
13. Flegal KM, "Trends in obesity among adults in the United States, 2005 to 2014", JAMA, 315, pp.2284~2291 (2016)
14. El Khoudary SR, "The menopause transition and women’s health at midlife : a progress report from the Study of Women’s Health Across the Nation(SWAN)", Menopause, 26, pp.1213~1227 (2019)
15. Tchkonia T, "Fat tissue, aging, and cellular senescence", Aging Cell, 9, pp.667~684 (2010)
16. Barazzoni R, "Sarcopenic obesity : time to meet the challenge", Obes Facts, 11, pp.294~305 (2018)
17. Donini LM, "Definition and diagnostic criteria for sarcopenic obesity : ESPEN and EASO consensus statement", Obes Facts, 15, pp.321~335 (2022)
18. Cruz-Jentoft AJ, "Sarcopenia: European consensus on definition and diagnosis:report of the European Working Group on Sarcopenia in Older People", Age Ageing, 39, pp.412~423 (2010)
19. Makizako H, "Frailty and sarcopenia as a geriatric syndrome in community-dwelling older adults", Int J Environ Res Public Health, 16, pp.4013~ (2019)
20. Hong SH, "Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences", Int J Mol Sci, 21, pp.494~ (2020)
21. Frankenfield DC, "Limits of body mass index to detect obesity and predict body composition", Nutrition, 17, pp.26~30 (2001)
22. Kanis JA, "The diagnosis of osteoporosis", J Bone Miner Res, 9, pp.1137~1141 (1994)
23. Cho Y, "Sarcopenic obesity is associated with lower indicators of psychological health and quality of life in Koreans", Nutr Res, 35, pp.384~392 (2015)
24. Chung JH, "Association between sarcopenic obesity and bone mineral density in middle-aged and elderly Korean", Ann Nutr Metab, 68, pp.77~84 (2016)
25. Chung JY, "Body composition and its association with cardiometabolic risk factors in the elderly : a focus on sarcopenic obesity", Arch Gerontol Geriatr, 56, pp.270~278 (2013)
26. Hwang B, "Prevalence rate and associated factors of sarcopenic obesity in Korean elderly population", J Korean Med Sci, 27, pp.748~755 (2012)
27. Rossi AP, "Dynapenic abdominal obesity as a predictor of worsening disability, hospitalization, and mortality in older adults : results from the InCHIANTI study", J Gerontol A Biol Sci Med Sci, 72, pp.1098~1104 (2017)
28. Silva Neto LS, "Association between sarcopenia, sarcopenic obesity, muscle strength and quality of life variables in elderly women", Rev Bras Fisioter, 16, pp.360~367 (2012)
29. Tyrovolas S, "The role of muscle mass and body fat on disability among older adults : a cross-national analysis", Exp Gerontol, 69, pp.27~35 (2015)
30. Batsis JA, "Sarcopenia, sarcopenic obesity and mortality in older adults : results from the National Health and Nutrition Examination Survey III", Eur J Clin Nutr, 68, pp.1001~1007 (2014)
31. Kim YS, "Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys", J Gerontol A Biol Sci Med Sci, 67, pp.1107~1113 (2012)
32. Yin T, "The association between sarcopenic obesity and hypertension, diabetes, and abnormal lipid metabolism in Chinese adults", Diabetes Metab Syndr Obes, 14, pp.1963~1973 (2021)
33. Gonzalez A, "The critical role of oxidative stress in sarcopenic obesity", Oxid Med Cell Longev, 2021, pp.4493817~ (2021)
34. LaMonte MJ, "Physical activity, cardiorespiratory fitness, and adiposity : contributions to disease risk", Curr Opin Clin Nutr Metab Care, 9, pp.540~546 (2006)
35. Villareal DT, "Obesity in older adults : technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society", Am J Clin Nutr, 82, pp.923~934 (2005)
36. Sakuma K, "Sarcopenic obesity and endocrinal adaptation with age", Int J Endocrinol, 2013, pp.204164~ (2013)
37. Cruz-Jentoft AJ, "Understanding sarcopenia as a geriatric syndrome", Curr Opin Clin Nutr Metab Care, 13, pp.1~7 (2010)
38. La Colla A, "17β-estradiol and testosterone in sarcopenia : role of satellite cells", Ageing Res Rev, 24, pp.166~177 (2015)
39. Ouchi N, "Adipokines in inflammation and metabolic disease", Nat Rev Immunol, 11, pp.85~97 (2011)
40. Rolland Y, "Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women : the EPIDOS(EPIDemiologie de l’OSteoporose)study", Am J Clin Nutr, 89, pp.1895~1900 (2009)
41. Powell-Wiley TM, "Obesity and cardiovascular disease: a scientific statement from the American Heart Association", Circulation, 143, pp.e984~e1010 (2021)
42. Alberti KG, "Harmonizing the metabolic syndrome:a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
43. Morley JE, "Sarcopenia", J Lab Clin Med, 137, pp.231~243 (2001)
44. Abellan van Kan G, "Epidemiology and consequences of sarcopenia", J Nutr Health Aging, 13, pp.708~712 (2009)
45. Batsis JA, "Sarcopenic obesity in older adults : aetiology, epidemiology and treatment strategies", Nat Rev Endocrinol, 14, pp.513~537 (2018)
46. Atkins JL, "Sarcopenic obesity in ageing : cardiovascular outcomes and mortality", Br J Nutr, 124, pp.1102~1113 (2020)
47. Roh E, "Health consequences of sarcopenic obesity : a narrative review", Front Endocrinol (Lausanne), 11, pp.332~ (2020)
48. Zhang X, "Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings : a updated meta-analysis", BMC Geriatr, 19, pp.183~ (2019)
49. Evans K, "Sarcopenic obesity as a determinant of cardiovascular disease risk in older people : a systematic review", Postgrad Med, 133, pp.831~842 (2021)
50. Misra D, "Risk of knee osteoarthritis with obesity, sarcopenic obesity, and sarcopenia", Arthritis Rheumatol, 71, pp.232~237 (2019)
51. Lee S, "Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity : a cross-sectional study", Arthritis Rheum, 64, pp.3947~3954 (2012)
52. Luppino FS, "Overweight, obesity, and depression : a systematic review and meta-analysis of longitudinal studies", Arch Gen Psychiatry, 67, pp.220~229 (2010)
53. Istvan J, "Body weight and psychological distress in NHANES I", Int J Obes Relat Metab Disord, 16, pp.999~1003 (1992)
54. Hamer M, "Sarcopenic obesity and risk of new onset depressive symptoms in older adults : English Longitudinal Study of Ageing", Int J Obes (Lond), 39, pp.1717~1720 (2015)
55. Trouwborst I, "Exercise and nutrition strategies to counteract sarcopenic obesity", Nutrients, 10, pp.605~ (2018)
56. Kritchevsky SB, "Intentional weight loss and all-cause mortality : a meta-analysis of randomized clinical trials", PLoS One, 10, pp.e0121993~ (2015)
57. Heymsfield SB, "Weight loss composition is one-fourth fat-free mass : a critical review and critique of this widely cited rule", Obes Rev, 15, pp.310~321 (2014)
58. Zibellini J, "Effect of diet-induced weight loss on muscle strength in adults with overweight or obesity-a systematic review and meta-analysis of clinical trials", Obes Rev, 17, pp.647~663 (2016)
59. Polyzos SA, "Sarcopenic obesity", Hormones (Athens), 17, pp.321~331 (2018)
60. Molino S, "Sarcopenic obesity : an appraisal of the current status of knowledge and management in elderly people", J Nutr Health Aging, 20, pp.780~788 (2016)
61. Jang YJ, "The effects of protein and supplements on sarcopenia in human clinical studies : how older adults should consume protein and supplements", J Microbiol Biotechnol, 33, pp.143~150 (2023)
62. Daly RM, "Independent and combined effects of exercise and vitamin D on muscle morphology, function and falls in the elderly", Nutrients, 2, pp.1005~1017 (2010)
63. Becker C, "Myostatin antibody (LY2495655)in older weak fallers: a proof-of-concept, randomised, phase 2trial", Lancet Diabetes Endocrinol, 3, pp.948~957 (2015)
64. Makimura H, "Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion : a randomized controlled trial", J Clin Endocrinol Metab, 97, pp.4769~4779 (2012)
65. Mangan G, "Delay in post-ovariectomy estrogen replacement negates estrogen-induced augmentation of post-exercise muscle satellite cell proliferation", Can J Physiol Pharmacol, 93, pp.945~951 (2015)
66. Ronkainen PH, "Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function : a study with monozygotic twin pairs", J Appl Physiol(1985), 107, pp.25~33 (2009)
67. Kenny AM, "Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogenreplacement therapy", J Gerontol A Biol Sci Med Sci, 58, pp.M436~M440 (2003)
68. Espeland MA, "Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators", J Clin Endocrinol Metab, 82, pp.1549~1556 (1997)
69. Miller VT, "Effects of estrogen or estrogen", progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen, JAMA, pp.1995, 273[DOI]
70. Reubinoff BE, "Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women : a prospective study", Fertil Steril, 64, pp.963~968 (1995)
71. Utian WH, "Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight", Maturitas, 1, pp.3~8 (1978)
72. Björkelund C, "Reproductive history in relation to relative weight and fat distribution", Int J Obes Relat Metab Disord, 20, pp.213~219 (1996)

관련 논문AI추천